Quest Diagnostics…
USUSDQuest Diagnostics Incorporated (LSE:0KSX) — Medical Specialities. Number of exchanges where the company shares trade: 2. On this page — price and chart, dividends, top holders and share count history.
About the company
- Website
- questdiagnostics.com
- Investor relations
- ir.questdiagnostics.com/overview/default.aspx
- Sector
- Health Care · Medical Specialities
- Headquarters
- Madison, United States
- CEO
- Steve Rusckowski
- Employees
- 46 000
- Founded
- 1967
- Listed since
- 29.01.2018 (LSE:0KSX)
- Shares outstanding
- 110.37 M as of 2026-07-15
- Free float
- 109.81 M
- Market cap
- 25.21 B USD
- Insiders
- 0.43%
- Institutions
- 98.9%
- Industry (SIC)
- Services-Medical Laboratories
- LEI
- 8MCWUBXQ0WE04KMXBX50
- P/E
- 15.4
- Payout ratio
- 34.2%
- FCF
- 1.35 B USD
- Payout / FCF
- 27%
- Debt
- 5.64 B USD3.7 y of FCF
- Dividend streak
- 22 y
- Earnings, FCF and dividends paid — for the 12 months to 30.06.2026 (the company's latest report).
- NAV
Description
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Dividends
Quest Diagnostics Incorporated (DGX) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 3.38 USD per share (payments: 4). That is about 1.44% of the current share price. Based on payment history, the next ex-dividend date is expected around 05.01.2027. Uninterrupted dividend history: 22 years.
| Ex-date | Payment | Amount | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-21 | 0.8600 USD | 0.4/1.5 % | quarterly | US:DGX |
| 2026-07-08 | 2026-07-22 | 0.8600 USD | 0.4/1.6 % | quarterly | US:DGX |
| 2026-04-06 | 2026-04-20 | 0.8600 USD | 0.4/1.6 % | quarterly | US:DGX |
| 2026-01-13 | 2026-01-28 | 0.8000 USD | 0.5/1.8 % | quarterly | US:DGX |
| 2025-10-03 | 2025-10-20 | 0.8000 USD | 0.4/1.7 % | quarterly | US:DGX |
| 2025-07-07 | 2025-07-21 | 0.8000 USD | 0.5/1.8 % | quarterly | US:DGX |
| 2025-04-07 | 2025-04-21 | 0.8000 USD | 0.5/1.9 % | quarterly | US:DGX |
| 2025-01-14 | 2025-01-29 | 0.7500 USD | 0.5/1.9 % | quarterly | US:DGX |
| 2024-10-04 | 2024-10-21 | 0.7500 USD | 0.3/1.3 % | quarterly | US:DGX |
| 2024-07-08 | 2024-07-22 | 0.7500 USD | 0.3/1.2 % | quarterly | US:DGX |
| 2024-04-05 | 2024-04-22 | 0.7500 USD | 0.3/≈1.3 % | quarterly | US:DGX |
| 2024-01-16 | 2024-01-31 | 0.7100 USD | 0.3/≈1.2 % | quarterly | US:DGX |
| 2023-10-05 | 2023-10-23 | 0.7100 USD | 0.3/≈1.2 % | quarterly | US:DGX |
News this week
Press releases from the company's investor website, updated daily. Links lead to the company's website. Headlines are in the original language, as on the company website.
Top holders
| Holder | Stake | Shares | Report date |
|---|---|---|---|
| Blackrock Inc. | 8.4% | 9.28 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.55% | 7.23 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 5.55% | 6.13 M | 2026-06-30 |
| State Street Corporation | 5% | 5.52 M | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.93% | 5.44 M | 2026-06-30 |
| Boston Partners | 4.3% | 4.74 M | 2026-06-30 |
| JPMORGAN CHASE & CO | 3.19% | 3.52 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.51 M | 2026-06-30 |
| Geode Capital Management… | 2.84% | 3.14 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 2.87 M | 2026-06-30 |
| Morgan Stanley | 2.23% | 2.46 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.17% | 2.4 M | 2026-06-30 |
| Edgepoint Investment Gro… | 2.04% | 2.25 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.33% | 1.47 M | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 1.43 M | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 1.36 M | 2026-08-31 |
| John Hancock Funds III-D… | 1.09% | 1.2 M | 2026-07-31 |
| JPMorgan Trust II-JPMorg… | 1.04% | 1.15 M | 2026-06-30 |
| T. Rowe Price Dividend G… | 1% | 1.11 M | 2026-06-30 |
| John Hancock Funds III-D… | 0.96% | 1.06 M | 2026-07-31 |
| DAVIS J E CAUSEY (Chief… | ≈0.13% | 142 423 | 2026-03-04 |
| DAVIS JAMES E (Chief Exe… | ≈0.11% | 122 423 | 2026-09-01 |
| DOHERTY CATHERINE T (Off… | ≈0.06% | 71 624 | 2026-03-05 |
| PREVOZNIK MICHAEL E (Gen… | ≈0.04% | 42 337 | 2026-08-28 |
| DEPPE MICHAEL J (Officer… | ≈0.03% | 35 196 | 2026-03-04 |
| SAMAD SAMER ABDUL (Chief… | ≈0.03% | 33 478 | 2026-07-22 |
| RING TIMOTHY M (Director… | ≈0.03% | 31 140 | 2026-05-20 |
| PFEIFFER GARY M (Directo… | ≈0.03% | 31 005 | 2026-05-20 |
| MAIN TIMOTHY L (Director… | ≈0.02% | 27 460 | 2026-07-22 |
| GREGG VICKY B (Director) | ≈0.02% | 18 386 | 2026-07-22 |
